Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients
- 17 February 2011
- journal article
- research article
- Published by Taylor & Francis in Social Neuroscience
- Vol. 6 (1) , 88-97
Abstract
A large body of evidence links altered opioid signaling with changes in social behavior in animals. However, few studies have attempted to determine whether similar links exist in humans. Here we investigate whether a common polymorphism (A118G) in the mu-opioid receptor gene (OPRM1) is associated with alterations in personality traits linked to affiliative behavior and attachment. In a mixed sample (N = 214) of adult healthy volunteers and psychiatric patients, we analyzed the association between the A118G polymorphism of the OPRM1 and two different psychological constructs reflecting individual differences in the capacity to experience social reward. Compared to individuals expressing only the major allele (A) of the A118G polymorphism, subjects expressing the minor allele (G) had an increased tendency to become engaged in affectionate relationships, as indicated by lower scores on a self-report measure of avoidant attachment, and experienced more pleasure in social situations, as indicated by lower scores on a self-report measure of social anhedonia. The OPRM1 variation accounted for about 3.5% of the variance in the two measures. The significant association between the A118G polymorphism and social hedonic capacity was independent of the participants' mental health status. The results reported here are in agreement with the brain opioid hypothesis of social attachment and the established role of opioid transmission in mediating affiliative behavior.Keywords
This publication has 38 references indexed in Scilit:
- Variation in the μ-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejectionProceedings of the National Academy of Sciences, 2009
- Functional characterization of human variants of the mu-opioid receptor geneProceedings of the National Academy of Sciences, 2009
- A118G Single Nucleotide Polymorphism of Human μ-Opioid Receptor Gene Influences Pain Perception and Patient-controlled Intravenous Morphine Consumption after Intrathecal Morphine for Postcesarean AnalgesiaAnesthesiology, 2008
- Individual Attachment Style Modulates Human Amygdala and Striatum Activation during Social AppraisalPLOS ONE, 2008
- Human Expression Variation in the Mu-Opioid Receptor is Paralleled in Rhesus MacaqueBehavior Genetics, 2008
- Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primatesProceedings of the National Academy of Sciences, 2008
- Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between2008
- The assessment of anhedonia in clinical and non-clinical populations: Further validation of the Snaith–Hamilton Pleasure Scale (SHAPS)Journal of Affective Disorders, 2007
- Effect of the A118G polymorphism on binding affinity, potency and agonist‐mediated endocytosis, desensitization, and resensitization of the human mu‐opioid receptorJournal of Neurochemistry, 2004
- Rethinking Behavior GeneticsScience, 2002